APGE
Apogee Therapeutics·NASDAQ
--
--(--)
--
--(--)
6.70 / 10
Outperform
Analyst consensus is heavily bullish: 83.3% Strong Buy, 16.7% Neutral. Fund‑flow score 7.78 (good) with positive inflows across all size categories. Sentiment is Outperform, indicating strong liquidity and conviction.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
83%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-18
InstitutionTruist Securities
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of APGE?
- APGE holds a Bullish analyst rating, with 83% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.70/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
